Polyprodrug Nanomedicines: An Emerging Paradigm for Cancer Therapy

Author:

Yang Kuikun1,Yang Zhiqing23,Yu Guocan4,Nie Zhihong5,Wang Ruibing23,Chen Xiaoyuan678ORCID

Affiliation:

1. School of Life Science and Technology Harbin Institute of Technology Harbin Heilongjiang 150080 P. R. China

2. State Key Laboratory of Quality Research in Chinese Medicine Institute of Chinese Medical Science University of Macau Avenida da Universidade Taipa Macau 999078 P. R. China

3. MoE Frontiers Science Center for Precision Oncology University of Macau Macau P. R. China

4. Key Lab of Bioorganic Phosphorus Chemistry & Chemical Biology Department of Chemistry Tsinghua University Beijing 100084 P. R. China

5. State Key Laboratory of Molecular Engineering of Polymers Department of Macromolecular Science Fudan University Shanghai 200438 P. R. China

6. Departments of Diagnostic Radiology Surgery, Chemical and Biomolecular Engineering and Biomedical Engineering Yong Loo Lin School of Medicine and Faculty of Engineering National University of Singapore Singapore 119074 Singapore

7. Clinical Imaging Research Centre Centre for Translational Medicine Yong Loo Lin School of Medicine National University of Singapore Singapore 117599 Singapore

8. Nanomedicine Translational Research Program NUS Center for Nanomedicine Yong Loo Lin School of Medicine National University of Singapore Singapore 117597 Singapore

Funder

Science and Technology Development Fund

Universidade de Macau

National Natural Science Foundation of China

Publisher

Wiley

Subject

Mechanical Engineering,Mechanics of Materials,General Materials Science

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3